Aurobindo gets FDA approval for exemestane tablets USP, 25 mg
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application exemestane tablets USP, 25 mg. Aurobindo Pharma’s exemestane tablets are an AB-rated generic equivalent to the reference listed drug (RLD), AROMASIN Tablets, manufactured by Pfizer. Exemestane tablets are indicated for adjuvant treatment of